Russell Alan J, Chief Scientific Officer of Edgewise Therapeutics ($EWTX), sold about $3.6 million in company shares across four open market transactions over the last year. His most recent sale occurred on November 12, 2025. These sales rank 2,386th among 11,678 individual insiders in our database, where the average is $8.6 million per person over 6.4 transactions. Russell Alan J made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 12, 2025 | Edgewise Therapeutics, Inc. | $EWTX | Russell Alan J | Chief Scientific Officer | S | Common Stock | 100000 | $21.12 | 23,400.0000 | 105,492,779 | 81.04% | 0.09% |
| Nov. 12, 2025 | Edgewise Therapeutics, Inc. | $EWTX | Russell Alan J | Chief Scientific Officer | M | Common Stock | 100000 | $0.18 | 123,400.0000 | 105,492,779 | 427.35% | 0.09% |
| Nov. 12, 2025 | Edgewise Therapeutics, Inc. | $EWTX | Russell Alan J | Chief Scientific Officer | M | Stock Option (Right to Buy) | 100000 | $0.00 | 1,147,365.0000 | 105,492,779 | 8.02% | 0.09% |
| Aug. 26, 2025 | Edgewise Therapeutics, Inc. | $EWTX | Russell Alan J | Chief Scientific Officer | M | Stock Option (Right to Buy) | 100000 | $0.00 | 1,247,365.0000 | 104,940,493 | 7.42% | 0.10% |
| Aug. 26, 2025 | Edgewise Therapeutics, Inc. | $EWTX | Russell Alan J | Chief Scientific Officer | S | Common Stock | 100000 | $14.60 | 23,400.0000 | 104,940,493 | 81.04% | 0.10% |
| Aug. 26, 2025 | Edgewise Therapeutics, Inc. | $EWTX | Russell Alan J | Chief Scientific Officer | M | Common Stock | 100000 | $0.18 | 123,400.0000 | 104,940,493 | 427.35% | 0.10% |
| Aug. 12, 2025 | Edgewise Therapeutics, Inc. | $EWTX | Russell Alan J | Chief Scientific Officer | M | Common Stock | 5781 | $0.00 | 25,307.0000 | 104,940,493 | 29.61% | 0.01% |
| Aug. 12, 2025 | Edgewise Therapeutics, Inc. | $EWTX | Russell Alan J | Chief Scientific Officer | S | Common Stock | 1907 | $13.39 | 23,400.0000 | 104,940,493 | 7.54% | 0.00% |
| Aug. 12, 2025 | Edgewise Therapeutics, Inc. | $EWTX | Russell Alan J | Chief Scientific Officer | M | Restricted Stock Units | 5781 | $0.00 | 17,344.0000 | 104,940,493 | 25.00% | 0.01% |
| Aug. 12, 2025 | Edgewise Therapeutics, Inc. | $EWTX | Russell Alan J | Chief Scientific Officer | A | Restricted Stock Units | 28125 | $0.00 | 28,125.0000 | 104,940,493 | 9999.99% | 0.03% |
| Aug. 12, 2025 | Edgewise Therapeutics, Inc. | $EWTX | Russell Alan J | Chief Scientific Officer | A | Stock Option (Right to Buy) | 168750 | $0.00 | 168,750.0000 | 104,940,493 | 9999.99% | 0.16% |
| May 1, 2025 | Edgewise Therapeutics, Inc. | $EWTX | Russell Alan J | Chief Scientific Officer | M | Common Stock | 5209 | $0.00 | 20,072.0000 | 95,130,053 | 35.05% | 0.01% |
| May 2, 2025 | Edgewise Therapeutics, Inc. | $EWTX | Russell Alan J | Chief Scientific Officer | S | Common Stock | 1551 | $16.45 | 18,521.0000 | 95,130,053 | 7.73% | 0.00% |
| May 1, 2025 | Edgewise Therapeutics, Inc. | $EWTX | Russell Alan J | Chief Scientific Officer | M | Restricted Stock Units | 5209 | $0.00 | 0.0000 | 95,130,053 | 100.00% | 0.01% |
| March 7, 2025 | Edgewise Therapeutics, Inc. | $EWTX | Russell Alan J | Chief Scientific Officer | M | Common Stock | 200 | $0.18 | 15,063.0000 | 92,414,626 | 1.35% | 0.00% |
| March 7, 2025 | Edgewise Therapeutics, Inc. | $EWTX | Russell Alan J | Chief Scientific Officer | S | Common Stock | 200 | $30.02 | 14,863.0000 | 92,414,626 | 1.33% | 0.00% |
| March 7, 2025 | Edgewise Therapeutics, Inc. | $EWTX | Russell Alan J | Chief Scientific Officer | M | Stock Option (Right to Buy) | 200 | $0.00 | 1,456,580.0000 | 92,414,626 | 0.01% | 0.00% |
| Feb. 5, 2025 | Edgewise Therapeutics, Inc. | $EWTX | Russell Alan J | Chief Scientific Officer | M | Common Stock | 8015 | $0.18 | 22,878.0000 | 92,414,626 | 53.93% | 0.01% |
| Feb. 5, 2025 | Edgewise Therapeutics, Inc. | $EWTX | Russell Alan J | Chief Scientific Officer | S | Common Stock | 8015 | $30.02 | 14,863.0000 | 92,414,626 | 35.03% | 0.01% |
| Feb. 6, 2025 | Edgewise Therapeutics, Inc. | $EWTX | Russell Alan J | Chief Scientific Officer | M | Common Stock | 1200 | $0.18 | 16,063.0000 | 92,414,626 | 8.07% | 0.00% |
| Feb. 6, 2025 | Edgewise Therapeutics, Inc. | $EWTX | Russell Alan J | Chief Scientific Officer | S | Common Stock | 1200 | $30.13 | 14,863.0000 | 92,414,626 | 7.47% | 0.00% |
| Feb. 5, 2025 | Edgewise Therapeutics, Inc. | $EWTX | Russell Alan J | Chief Scientific Officer | M | Stock Option (Right to Buy) | 8015 | $0.00 | 1,348,765.0000 | 92,414,626 | 0.59% | 0.01% |
| Feb. 6, 2025 | Edgewise Therapeutics, Inc. | $EWTX | Russell Alan J | Chief Scientific Officer | M | Stock Option (Right to Buy) | 1200 | $0.00 | 1,347,565.0000 | 92,414,626 | 0.09% | 0.00% |
| Dec. 30, 2024 | Edgewise Therapeutics, Inc. | $EWTX | Russell Alan J | Chief Scientific Officer | M | Stock Option (Right to Buy) | 100000 | $0.00 | 1,356,780.0000 | 93,813,346 | 6.86% | 0.11% |
| Dec. 30, 2024 | Edgewise Therapeutics, Inc. | $EWTX | Russell Alan J | Chief Scientific Officer | M | Common Stock | 100000 | $0.18 | 114,863.0000 | 93,813,346 | 672.81% | 0.11% |
| Dec. 30, 2024 | Edgewise Therapeutics, Inc. | $EWTX | Russell Alan J | Chief Scientific Officer | S | Common Stock | 100000 | $27.37 | 14,863.0000 | 93,813,346 | 87.06% | 0.11% |
| Sept. 20, 2024 | Edgewise Therapeutics, Inc. | $EWTX | Russell Alan J | Chief Scientific Officer | S | Common Stock | 815 | $29.51 | 12,719.0000 | 93,515,356 | 6.02% | 0.00% |
| Sept. 20, 2024 | Edgewise Therapeutics, Inc. | $EWTX | Russell Alan J | Chief Scientific Officer | M | Stock Option (Right to Buy) | 75000 | $0.00 | 1,456,780.0000 | 93,515,356 | 4.90% | 0.08% |
| Sept. 20, 2024 | Edgewise Therapeutics, Inc. | $EWTX | Russell Alan J | Chief Scientific Officer | S | Common Stock | 74185 | $28.25 | 13,534.0000 | 93,515,356 | 84.57% | 0.08% |
| Sept. 20, 2024 | Edgewise Therapeutics, Inc. | $EWTX | Russell Alan J | Chief Scientific Officer | M | Common Stock | 75000 | $0.18 | 87,719.0000 | 93,515,356 | 589.67% | 0.08% |
| Aug. 12, 2024 | Edgewise Therapeutics, Inc. | $EWTX | Russell Alan J | Chief Scientific Officer | A | Restricted Stock Units | 23125 | $0.00 | 23,125.0000 | 93,515,356 | 9999.99% | 0.02% |
| Aug. 12, 2024 | Edgewise Therapeutics, Inc. | $EWTX | Russell Alan J | Chief Scientific Officer | A | Stock Option (Right to Buy) | 138750 | $0.00 | 138,750.0000 | 93,515,356 | 9999.99% | 0.15% |
| May 2, 2024 | Edgewise Therapeutics, Inc. | $EWTX | Russell Alan J | Chief Scientific Officer | S | Common Stock | 1576 | $18.91 | 7,238.0000 | 87,567,307 | 17.88% | 0.00% |
| May 1, 2024 | Edgewise Therapeutics, Inc. | $EWTX | Russell Alan J | Chief Scientific Officer | M | Restricted Stock Units | 5208 | $0.00 | 5,209.0000 | 87,567,307 | 50.00% | 0.01% |
| May 1, 2024 | Edgewise Therapeutics, Inc. | $EWTX | Russell Alan J | Chief Scientific Officer | M | Common Stock | 5208 | $0.00 | 8,814.0000 | 87,567,307 | 144.43% | 0.01% |